Boardroom Media (CFO News)
At CFO (Boardroom Media) we track over 1,000,000 startups and over 5,000,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top Paris based CFO’ operating in the Life Science space. If you think a CFO’ is missing from this list, feel free to contact our editor on [email protected]
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Sylvain Cascarino
CFO of Kurma Partners
More than 15 years of experience in Finance & Administration. Previously entrepreneur and CFO for Nekazen/Le MAG VoD. Fund controller & Internal Auditor for Jones Lang LaSalle. Tax Advisor with Arthur Andersen. Sylvain joined Kurma in January 2013.
Follow Sylvain Cascarino:
About Kurma Partners: Kurma Partners is a management company specializing in the financing of innovation in healthcare and biotechnology.
Christelle Dumoussaud
Chief Financial Officer of ENTEROME
Christelle Dumoussaud has served as our Chief Financial Officer since 2015. Ms. Dumoussaud has more than 20 years’ experience in financial departments of various industries. In 2015, Ms. Dumoussaud served as General Secretary at Laboratoire Hepatoum-Dermophil Indien and Ms. Dumoussaud served as a financial consultant at Expert & Consult in 2014. From 2012 to 2013, Ms. Dumoussaud served as Administration and Finance Manager at Almavia and from 2007 to 2012, Ms. Dumoussaud served as General Secretary at Polygon/Munters France-Belgium. Ms. Dumoussaud worked at Fournier/Solvay Pharma from 1997 to 2007, serving as the Finance Director from 2005 to 2007. Ms. Dumoussaud served as the Chief Financial Officer of Fournier Pharma Belgium from 2001 to 2004. Ms. Dumoussaud holds a Master in Business Management from the ISC Paris.
Follow Christelle Dumoussaud:
About ENTEROME: Enterome is a clinical-stage company developing drugs for chronic medical conditions relating to abnormalities of bacterial composition.
Jérôme Vailland
Chief Financial Officer of Coave Therapeutics
Jérôme VAILLAND has 15 years of experience in audit, management, and transactions, and joined HORAMA CFO in November 2016. He began his career as a Financial Controller at Bouygues Telecom, and was subsequently hired as a Senior Manager by Ernst & Young, where he worked for 11 years in the fields of financial auditing, transaction advisory services, and IPO services, mainly in the life sciences industry, in addition to his managerial duties (team management, business development, recruitment, etc.). Jérôme is a graduate of Audencia-Nantes, where he majored in audit-financial control.
Follow Jérôme Vailland:
About Coave Therapeutics: Horama develops gene therapies for rare inherited ocular and CNS (central nervous system) diseases.
Gordon Waldron
Chief Financial Officer of Antabio
Gordon Waldron is the Chief Financial Officer at Antabio. Prior to joining SuperSonic Imagine in September 2010, Mr. Waldron spent five years as CFO for the French biotech company Novexel where he raised €50 million in 2006, negotiated a preclinical license agreement which brought the company a €75 million upfront payment in 2008 and directed a trade sale process resulting in the acquisition of Novexel by AstraZeneca for cash consideration of approximately $500 million in 2009. Before Novexel, he spent eight years as VP Finance with Synt:em (Nimes, France) where he raised €32 million in three financing rounds. Gordon also spent five years with Texas Instruments, first as Finance Director for a French subsidiary, then as Group Finance Manager (based in the UK) covering 17 entities and a distributor network for Texas Instruments Software in the Europe, Middle East and Africa territories. Mr. Waldron started his career with Spie Batignolles at its head office near Paris before becoming a controller of the company’s US subsidiaries based in Pittsburgh. He graduated from Duke University (USA) in 1988 and has both American and British nationalities.
Follow Gordon Waldron:
About Antabio, SuperSonic Imagine: Antabio is a private biopharmaceutical company developing antibacterial resistance-breakers in areas of highest medical need.
Laurent Guy
CFO of AB Science
Follow Laurent Guy:
About AB Science: AB Science is a pharmaceutical company specializing in drugs use tyrosine kinase inhibitors.
Laurent Guy
CFO of AB Science
Follow Laurent Guy:
About AB Science: AB Science is a pharmaceutical company specializing in drugs use tyrosine kinase inhibitors.
Baptiste Billoir
Co-Founder and CFO of AgenT
Follow Baptiste Billoir:
About AgenT: AgenT develops the first blood diagnosis to detect Alzheimer’s years before the onset of the irreversible symptoms.
